Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 0.00 is 100% below its estimated 1-year average of 0.02, near the low end of its estimated 1-year range (0.00–0.06).
As of 2026-10-06T14:51:22.360Z.
Calculation as of: 2026-10-06T14:51:22.360Z.
Quote observation: 2026-10-06T14:50:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 95041c5b42fb2606cad9ef3462ba84fd1ad3ee370422abc55eb90f4681bfa3ac
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
0.00
PS RATIO AVG TTM
N/A
PS RATIO AVG 3Y
N/A
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.04
median of 425 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$818355.00
PS Ratio
N/A
TTM Avg
2215.39
3Y Avg
2233.86
5Y Avg
2233.86
Market Cap
$861994.00
PS Ratio
N/A
TTM Avg
48450.87
3Y Avg
43764.18
5Y Avg
43764.18
Market Cap
$1.04M
PS Ratio
10.62
TTM Avg
20733.20
3Y Avg
20733.20
5Y Avg
20733.20
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CDT Equity Inc. (CDT) | $670533.00 | 0.00 | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $559702.00 | 0.08 | 5.16 | 225.96 | 406.71 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $818355.00 | N/A | 2215.39 | 2233.86 | 2233.86 |
| Decoy Therapeutics Inc. (DCOY)vs › | $837850.00 | N/A | 86.14 | 51.38 | 839.91 |
| GlucoTrack, Inc. (GCTK)vs › | $861994.00 | N/A | 48450.87 | 43764.18 | 43764.18 |
| Bone Biologics Corporation (BBLG)vs › | $870069.00 | N/A | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $379496.00 | N/A | N/A | N/A | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | 10.62 | 20733.20 | 20733.20 | 20733.20 |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | N/A | N/A | N/A | N/A |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-28 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-15 |
| Q1 FY2026Period ended 2026-03-29 | $696,375,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $750,157,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $1,446,532,000 |
Current P/S: $670,533 market capitalization ÷ $1,446,532,000 TTM revenue = 0.00x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:50:14.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 0.00, P/S is below its estimated 1-year median — higher than 0% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
0.01
median
0.02
estimated 1-year high
0.06
P/S Ratio
0.00
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 0.00 |
| 2026-10-02 | 0.00 |
| 2026-10-01 | 0.00 |
| 2026-09-30 | 0.00 |
| 2026-09-29 | 0.00 |
| 2026-09-28 | 0.00 |
| 2026-09-25 | 0.00 |
| 2026-09-24 | 0.00 |
| 2026-09-23 | 0.00 |
| 2026-09-22 | 0.00 |
| 2026-09-21 | 0.00 |
| 2026-09-18 | 0.00 |
| 2026-09-17 | 0.00 |
| 2026-09-16 | 0.00 |
| 2026-09-15 | 0.00 |
| 2026-09-14 | 0.00 |
| 2026-09-11 | 0.00 |
| 2026-09-10 | 0.00 |
| 2026-09-09 | 0.01 |
| 2026-09-08 | 0.01 |
| 2026-09-04 | 0.01 |
| 2026-09-03 | 0.01 |
| 2026-09-02 | 0.01 |
| 2026-09-01 | 0.01 |
| 2026-08-31 | 0.02 |
| 2026-08-28 | 0.02 |
| 2026-08-27 | 0.02 |
| 2026-08-26 | 0.02 |
| 2026-08-25 | 0.02 |
| 2026-08-24 | 0.02 |
| 2026-08-21 | 0.03 |
| 2026-08-20 | 0.03 |
| 2026-08-19 | 0.03 |
| 2026-08-18 | 0.03 |
| 2026-08-17 | 0.03 |
| 2026-08-14 | 0.03 |
| 2026-08-13 | 0.03 |
| 2026-08-12 | 0.01 |
| 2026-08-11 | 0.01 |
| 2026-08-10 | 0.01 |
| 2026-08-07 | 0.01 |
| 2026-08-06 | 0.01 |
| 2026-08-05 | 0.01 |
| 2026-08-04 | 0.01 |
| 2026-08-03 | 0.01 |
| 2026-07-31 | 0.01 |
| 2026-07-30 | 0.01 |
| 2026-07-29 | 0.01 |
| 2026-07-28 | 0.01 |
| 2026-07-27 | 0.01 |
| 2026-07-24 | 0.01 |
| 2026-07-23 | 0.01 |
| 2026-07-22 | 0.01 |
| 2026-07-21 | 0.01 |
| 2026-07-20 | 0.01 |
| 2026-07-17 | 0.01 |
| 2026-07-16 | 0.01 |
| 2026-07-15 | 0.01 |
| 2026-07-14 | 0.01 |
| 2026-07-13 | 0.01 |
| 2026-07-10 | 0.01 |
| 2026-07-09 | 0.01 |
| 2026-07-08 | 0.01 |
| 2026-07-07 | 0.01 |
| 2026-07-06 | 0.01 |
| 2026-07-02 | 0.01 |
| 2026-07-01 | 0.01 |
| 2026-06-30 | 0.01 |
| 2026-06-29 | 0.02 |
| 2026-06-26 | 0.02 |
| 2026-06-25 | 0.02 |
| 2026-06-24 | 0.03 |
| 2026-06-23 | 0.03 |
| 2026-06-22 | 0.04 |
| 2026-06-18 | 0.03 |
| 2026-06-17 | 0.02 |
| 2026-06-16 | 0.02 |
| 2026-06-15 | 0.02 |
| 2026-06-12 | 0.02 |
| 2026-06-11 | 0.02 |
| 2026-06-10 | 0.02 |
| 2026-06-09 | 0.02 |
| 2026-06-08 | 0.02 |
| 2026-06-05 | 0.02 |
| 2026-06-04 | 0.02 |
| 2026-06-03 | 0.02 |
| 2026-06-02 | 0.02 |
| 2026-06-01 | 0.02 |
| 2026-05-29 | 0.03 |
| 2026-05-28 | 0.02 |
| 2026-05-27 | 0.03 |
| 2026-05-26 | 0.02 |
| 2026-05-22 | 0.03 |
| 2026-05-21 | 0.03 |
| 2026-05-20 | 0.03 |
| 2026-05-19 | 0.03 |
| 2026-05-18 | 0.04 |
| 2026-05-15 | 0.05 |
| 2026-05-14 | 0.05 |
| 2026-05-13 | 0.06 |
| 2026-05-12 | 0.05 |
| 2026-05-11 | 0.05 |
| 2026-05-08 | 0.05 |
| 2026-05-07 | 0.05 |
| 2026-05-06 | 0.06 |
| 2026-05-05 | 0.05 |
| 2026-05-04 | 0.06 |
| 2026-05-01 | 0.06 |
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.